Track record · closed signal

Bio-Techne Corporation (TECH) — closed signal from October 21, 2025

Partial Published before the outcome was known, scored automatically when the window closed on January 19, 2026.

Predicted vs. what happened

TECH price · publication thesis → realized outcomesplit-adjusted
$63.37 Published $74.68 Target $68.67 Window close $70.66 Peak
$61.83 – $63.83Entry zone — fair-value band
$63.37Published — price the day we called it
$74.68Target — the price the thesis aimed for
$70.66Peak — highest point inside the window, not a realized return
$68.67Window close — end-of-window price, context only

What happened

Partial

Reached 64% of the predicted growth at its peak, without hitting the target.

Peak price
$70.66
peak on January 15, 2026 — not a realized return
Peak gain
+11.5%
peak, from the publication price
Window close
$68.67
end-of-window price, context only
Days to target
Window
October 21, 2025 – January 19, 2026

The thesis — published October 21, 2025

Predicted growth
+18%
over the measurement window
Target price
$74.68
the price the thesis aimed for
Entry zone
$61.83 – $63.83
the fair-value band we waited for
Price at publication
$63.37
published October 21, 2025
Confidence
62%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Bio-Techne shows a strengthening trend: lots more people are buying than usual, and the price is above its recent average. A new global distribution deal with Saguaro could widen reach, and shares rose about 20% last month. Risks remain because core sales growth looks muted. This is a short-term idea: consider buying small dips only if trading volume stays strong, aiming for a 0-3 month drift higher.

Primary drivers

  • New global distribution deal with Saguaro may meaningfully expand reach
  • Buying interest is rising and price is above its recent average
  • Stock jumped 20% last month, showing strong demand from investors
  • Core sales growth appears soft, so near-term results may be uneven

How it played out

TECH: thesis partly played out, target missed

Lyra published TECH on 2025-10-21 at $63.37 with an 18% expected gain and a $74.68 target. The thesis pointed to rising buying interest, a price above its recent average, a new global distribution deal with Saguaro, and a 20% jump last month. It also flagged soft core sales growth as a risk.

Inside the window, TECH rose but did not reach $74.68. The stock peaked at $70.66 on 2026-01-15, with an 11.5% gain, then ended at $68.67. The direction was right, but the target was missed. The thesis partly played out.

What happened during the window

On December 9, 2025, Bio-Techne announced the expanded launch and first shipment of its enhanced Leo System, saying it enabled up to 24 targets per sample. On December 11, 2025, Bio-Techne announced a collaboration with the Wyss Center Geneva to develop an automated workflow for RNA and protein detection in 3D specimens.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.